Etoricoxib

CHEMBL416146 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

358.8 g/mol

LogP

3.3

Phase

4

This selective COX-2 inhibitor reduces pain and inflammation by blocking the enzyme responsible for producing inflammatory chemicals while largely sparing the stomach-protecting COX-1 enzyme. It is used for arthritis, acute pain, and gout.

Moleküler Ağırlık

358,8000 g/mol

LogP

3,30

TPSA

68,30 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Pain Management Rheumatoid Arthritis Asthma Melanoma Gout Chronic Pain HIV/AIDS Tuberculosis Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1

InChI

InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3

Molecular Formula

C18H15ClN2O2S

HBD / HBA

- / 4

Döndürülebilir Bağlar

3

Ağır Atomlar

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This selective COX-2 inhibitor reduces pain and inflammation by blocking the enzyme responsible for producing inflammatory chemicals while largely sparing the stomach-protecting COX-1 enzyme. It is used for arthritis, acute pain, and gout.

Yes, Etoricoxib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL416146. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 123619. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Etoricoxib PillFYI'da

Yapı

Hızlı Veriler

Formül: C18H15ClN2O2S

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.